Vaccine and Treatment Evaluation Units: Phase I Clinical Trial to Evaluate a Universal Influenza Vaccine Candidate

疫苗和治疗评估单位：评估通用流感候选疫苗的 I 期临床试验

• 批准号: 9915649
• 负责人: DANIEL HOFT
• 金额: $ 5.6万
• 依托单位: SAINT LOUIS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-07-12 至 2021-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9915649
• 关键词: Childhood; Communicable Diseases; Conduct Clinical Trials; Contracts; Evaluation; Individual; Influenza A virus; Phase I Clinical Trials; Population; Resources; Vaccines; combat; design; named group; phase I trial; programs; universal influenza vaccine; vaccine candidate

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

该计划由学术中心和组织内的个人合同联盟组成，为临床试验的设计和实施提供现成的资源，以评估有前景的抗击传染病的产品。一般来说，产品会在正常健康人群中进行评估；然而，也可以接触特殊人群。